Adriaan Fruijtier is currently Director Regulatory Affairs for CATS Consultants GmbH. Prior to joining CATS, he served as Head of the Oncology Group within the Global Regulatory Affairs division at Bayer AG in Wuppertal, Germany and the Bayer Corporation. He has also worked for the European Medicines Agency in London.
Previously, Mr. Fruijtier served as Director of Regulatory Affairs at Micromet AG and Regulatory Affairs Project Manager at Novartis AG in Basel, Switzerland. He also spent six years as Head of Drug Regulatory Affairs for Ciba-Geigy in the Netherlands.
Mr. Fruijtier received his M.Sc. in Pharmacy from the University of Utrecht, Netherlands.